Options for low-risk prostate cancer – 2
Narrator: This is NIH Health Matters. I’m Joe Balintfy. For men diagnosed with localized, low-risk prostate cancer, a strategy of close monitoring and delayed treatment may be a better option than immediate surgery or radiation therapy.
Ganz: Men may be getting treatments that are not necessarily going to change their life course and their survival.
Narrator: Dr. Patricia Ganz from UCLA has chaired an independent NIH panel who’s findings suggest the treatments have serious short- and long-term side effects.
Ganz: By taking an approach that delays or perhaps never requires that kind of intervention, they may be spared that.
Narrator: She adds slow-growing prostate cancer may pose a lower risk than those treatments. For more information on the panel’s findings, visit the website consensus.nih.gov. Health Matters is produced by the NIH, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.